Background
Methods
Seek, test, treat, and retain (STTR) data collection and harmonization initiative
Study | Geographic Location | Population | Recent substance use | Substance use before/during sex | Reference Period | Participants Contributing Data |
---|---|---|---|---|---|---|
BCAP | Brooklyn, NY | Heterosexual individuals at high risk for HIV infection | Yes | Yes | 30 days | 2133 (31.5) |
BRIGHT | Baltimore City, MD & Providence, RI | Probationers/ parolees | Yes | No | 90 days | 1537 (22.7) |
STAR | New York, NY | African American substance-using men at risk for STI/HIV | Yes | Yes | 30 days | 768 (11.3) |
STTS | Milwaukee County, WI | Detainees in the Wisconsin prison system detention center | Yes | No | 90 days | 2343 (34.6) |
TOTAL | 6781 |
Recruitment and sampling
Data sources
Statistical analyses
Recent substance use
Substance Use Category | |||||
---|---|---|---|---|---|
Total | None | Single-Substance | Polysubstance | ||
N | N | 6781 | 3292 (48.6) | 2222 (32.8) | 1267 (18.7) |
Male | 6781 | 5573 (82.2) | 2623 (79.7) | 1814 (81.6) | 1136 (89.7) |
Age | 6781 | 33 (26–45) | 32 (25–44) | 34 (26–45) | 37 (27–47) |
Race/Ethnicity | 6781 | ||||
Black or African American | 4073 (60.1) | 2246 (68.2) | 1280 (57.6) | 547 (43.2) | |
White | 748 (11.0) | 252 (7.7) | 209 (9.4) | 287 (22.7) | |
Hispanic or Latino | 1588 (23.4) | 620 (18.8) | 619 (27.9) | 349 (27.6) | |
Other race | 111 (1.6) | 52 (1.6) | 34 (1.5) | 25 (2.0) | |
Two or more races | 261 (3.9) | 122 (3.7) | 80 (3.6) | 59 (4.7) | |
Sexual Orientationb | 5244 | ||||
Heterosexual/Straight | 4289 (81.8) | 2191 (90.1) | 1363 (77.8) | 735 (69.3) | |
Homosexual/Gay/Lesbian/Queer/“Down-Lo” | 62 (1.2) | 13 (0.5) | 22 (1.3) | 27 (2.6) | |
Bisexual/Other | 868 (16.6) | 219 (9.0) | 356 (20.3) | 293 (27.6) | |
Refused/Missing | 25 (0.5) | 8 (0.3) | 12 (0.7) | 5 (0.5) | |
Education | 6781 | ||||
High school or less | 5270 (77.7) | 2587 (78.6) | 1710 (77.0) | 973 (76.8) | |
Some college | 1351 (19.9) | 635 (19.3) | 456 (20.5) | 260 (20.5) | |
College graduate or above | 157 (2.3) | 67 (2.0) | 56 (2.5) | 34 (2.7) | |
Refused/Missing | 3 (< 0.1) | 3 (0.1) | 0 | 0 | |
Risk Behaviorsc | 6781 | ||||
Number of sex partners | 1 (1–3) | 1 (1–2) | 2 (1–3) | 2 (1–4) | |
Unprotected sex | 5435 (80.2) | 2528 (76.8) | 1845 (83.0) | 1062 (83.8) | |
Injection Drug Use | |||||
Ever IDU | 976 (14.4) | 280 (8.5) | 231 (10.4) | 465 (36.7) | |
Recent IDU | 355 (5.2) | – | 64 (2.9) | 291 (23.0) | |
Substance Usec | 6781 | ||||
Alcohol | 4142 (61.1) | 1116 (33.9) | 1946 (87.6) | 1080 (85.2) | |
Binge alcohol | 2734 (40.3) | – | 1787 (80.4) | 947 (74.7) | |
Cocaine/crack | 907 (13.4) | – | 107 (4.8) | 800 (63.1) | |
Illicit opioids | 917 (13.5) | – | 178 (8.0) | 739 (58.3) | |
Methamphetamine/stimulants | 361 (5.3) | – | 47 (2.1) | 314 (24.8) | |
Cannabis | 2370 (35.0) | 734 (22.3) | 896 (40.3) | 740 (58.4) | |
Other | 628 (9.3) | – | 103 (4.6) | 525 (41.4) |
Substance use before/during sex
Time frame sensitivity analysis
Results
Recent substance use
Recent substance use | RR | 95% CI | p-value |
---|---|---|---|
Overall | |||
Nonea | Ref | – | – |
Single substance | 1.08 | 1.05–1.11 | < 0.001 |
Polysubstance | 1.09 | 1.05–1.13 | < 0.001 |
Single- vs. poly-substance | 1.02 | 0.99–1.05 | 0.26 |
Overall – Illicit substance use only | |||
Noneb | Ref | – | – |
Single substance | 1.06 | 1.02–1.09 | 0.002 |
Polysubstance | 1.09 | 1.05–1.13 | < 0.001 |
Single- vs. poly-substance | 1.01 | 0.97–1.05 | 0.68 |
By type of sex | |||
Vaginal sex only | Ref | – | – |
Vaginal and anal sex | 1.21 | 1.16–1.26 | < 0.001 |
Vaginal sex only | |||
Nonea | Ref | – | – |
Single substance | 1.09 | 1.05–1.14 | < 0.001 |
Polysubstance | 1.10 | 1.05–1.15 | < 0.001 |
Single- vs. poly-substance | 1.01 | 0.96–1.05 | 0.81 |
Vaginal and anal sex | |||
Nonea | Ref | – | – |
Single substance | 1.05 | 1.02–1.09 | 0.004 |
Polysubstance | 1.08 | 1.04–1.12 | < 0.001 |
Single- vs. poly-substance | 1.03 | 0.99–1.06 | 0.12 |
By HIV status of partner | |||
HIV-negative partners only | Ref | – | – |
HIV-unknown partners only | 0.92 | 0.86–0.98 | 0.01 |
HIV-negative & HIV-unknown partners only | 1.11 | 1.04–1.19 | 0.001 |
HIV-negative partners only | |||
Nonea | Ref | ||
Single substance | 1.08 | 1.02–1.13 | 0.004 |
Polysubstance | 1.07 | 1.01–1.14 | 0.02 |
Single- vs. poly-substance | 0.99 | 0.94–1.05 | 0.81 |
HIV-unknown partners only | |||
Nonea | Ref | – | – |
Single substance | 1.04 | 0.95–1.13 | 0.39 |
Polysubstance | 0.97 | 0.88–1.07 | 0.57 |
Single- vs. poly-substance | 0.94 | 0.85–1.03 | 0.20 |
HIV-negative & HIV-unknown partners only | |||
Nonea | Ref | – | – |
Single substance | 1.09 | 1.01–1.18 | 0.03 |
Polysubstance | 1.13 | 1.06–1.20 | < 0.001 |
Single- vs. poly-substance | 1.04 | 0.98–1.10 | 0.22 |
Substance use before or during sex
Substance use before/during sex | ||||
---|---|---|---|---|
Total | No | Yes | ||
N | N | 2915 | 1397 (47.9) | 1518 (52.1) |
Male | 2915 | 2021 (69.3) | 758 (54.3) | 1263 (83.2) |
Age | 2915 | 40 (28–49) | 37 (26–48) | 41 (29–49) |
Race/Ethnicity | 2915 | |||
Black or African American | 1701 (58.4) | 912 (65.3) | 789 (52.0) | |
White | 0 | 0 | 0 | |
Hispanic or Latino (alone or in combination with race) | 1169 (40.1) | 460 (32.9) | 709 (46.7) | |
Two or more races | 45 (1.5) | 25 (1.8) | 20 (1.3) | |
Sexual Orientation | 2915 | |||
Heterosexual/Straight | 2002 (68.7) | 1168 (83.6) | 834 (54.9) | |
Homosexual/Gay/Lesbian/Queer/Down-Lo | 55 (1.9) | 13 (0.9) | 42 (2.8) | |
Bisexual/Other | 843 (28.9) | 212 (15.2) | 631 (41.6) | |
Refused/DK/Missing | 15 (0.5) | 4 (0.3) | 11 (0.7) | |
Education | 2915 | |||
High school or less | 2251 (77.2) | 1084 (77.6) | 1167 (76.9) | |
Some college | 572 (19.6) | 278 (19.9) | 294 (19.4) | |
College graduate or above | 91 (3.1) | 34 (2.4) | 57 (3.8) | |
Refused/DK/Missing | 1 (< 0.1) | 1 (0.1) | 0 | |
Risk Behaviorsa | 2915 | |||
Number of sex partners | 2 (1–3) | 1 (1–2) | 2 (1–3) | |
Unprotected sex | 2425 (83.2) | 1110 (79.5) | 1315 (86.6) | |
Injection Drug Use | ||||
Ever IDU | 371 (12.7) | 116 (8.3) | 255 (16.8) | |
Recent IDU | 92 (3.2) | 8 (0.6) | 84 (5.5) | |
Substance Usea | 2915 | |||
Alcohol | 2133 (73.2) | 812 (58.1) | 1321 (87.0) | |
Binge alcohol | 1419 (48.7) | 437 (31.3) | 982 (64.7) | |
Cocaine/crack | 334 (11.5) | 19 (1.4) | 315 (20.8) | |
Illicit opioids | 285 (9.8) | 17 (1.2) | 268 (17.7) | |
Methamphetamine/stimulants | 73 (2.5) | 10 (0.7) | 63 (4.2) | |
Cannabis | 899 (30.8) | 192 (13.7) | 707 (46.6) | |
Other | 180 (6.2) | 19 (1.4) | 161 (10.6) | |
Polysubstance | 1039 (35.6) | 175 (12.5) | 864 (56.9) |
Substance use before/during sex | RR | 95% CI | p-value |
---|---|---|---|
Overall | |||
No | Ref | – | – |
Yes | 1.16 | 1.12–1.20 | < 0.001 |
By type of sex | |||
Vaginal sex only | Ref | – | – |
Vaginal and anal sex | 1.18 | 1.11–1.26 | < 0.001 |
Vaginal sex only | |||
No | Ref | – | – |
Yes | 1.20 | 1.12–1.29 | < 0.001 |
Vaginal and anal sex | |||
No | Ref | – | – |
Yes | 1.07 | 1.03–1.11 | 0.002 |
Time frame sensitivity analysis
Sensitivity analyses with Cannabis
Discussion
Strengths
Limitations
Conclusion
Acknowledgements
Declarations
Ethics approval and consent to participate
-
BCAP, New York University
-
BRIGHT, Friends Research Institute
-
STAR, Columbia University
-
STTS, University of Wisconsin-Milwaukee